Ionis Pharmaceuticals, Inc.
COMPOSITIONS AND METHODS FOR MODULATING COMPLEMENT FACTOR B EXPRESSION
Last updated:
Abstract:
The present embodiments provide methods, compounds, and compositions for treating, preventing, or ameliorating a disease associated with dysregulation of the complement alternative pathway by administering a Complement Factor B (CFB) specific inhibitor to a subject.
Status:
Application
Type:
Utility
Filling date:
18 Mar 2019
Issue date:
13 Feb 2020